Logo image of EMO

CLEARBRIDGE ENERGY MIDSTREAM (EMO) Stock Price, Quote, News and Overview

NYSE:EMO - New York Stock Exchange, Inc. - US18469P2092 - Currency: USD

47.87  +0.48 (+1.01%)

Fundamental Rating

3

Taking everything into account, EMO scores 3 out of 10 in our fundamental rating. EMO was compared to 0 industry peers in the Unkown industry. The financial health of EMO is average, but there are quite some concerns on its profitability. EMO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EMO had positive earnings in the past year.
EMO had a positive operating cash flow in the past year.
Of the past 5 years EMO 4 years were profitable.
In multiple years EMO reported negative operating cash flow during the last 5 years.
EMO Yearly Net Income VS EBIT VS OCF VS FCFEMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

Industry RankSector Rank
ROA 41.32%
ROE 59.6%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMO Yearly ROA, ROE, ROICEMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

In the last couple of years the Profit Margin of EMO has declined.
EMO does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 2119.25%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.55%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMO Yearly Profit, Operating, Gross MarginsEMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K -6K

More info and screens

4

2. Health

2.1 Basic Checks

There is no outstanding debt for EMO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EMO Yearly Shares OutstandingEMO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
EMO Yearly Total Debt VS Total AssetsEMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

EMO has an Altman-Z score of 1.92. This is not the best score and indicates that EMO is in the grey zone with still only limited risk for bankruptcy at the moment.
The Debt to FCF ratio of EMO is 0.52, which is an excellent value as it means it would take EMO, only 0.52 years of fcf income to pay off all of its debts.
EMO has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
Although EMO does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.52
Altman-Z 1.92
ROIC/WACCN/A
WACCN/A
EMO Yearly LT Debt VS Equity VS FCFEMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 4.03 indicates that EMO has no problem at all paying its short term obligations.
EMO has a Quick Ratio of 4.03. This indicates that EMO is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.03
Quick Ratio 4.03
EMO Yearly Current Assets VS Current LiabilitesEMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 213.41% over the past year.
Measured over the past years, EMO shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.58% on average per year.
EMO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.54%.
EMO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.84% yearly.
EPS 1Y (TTM)213.41%
EPS 3Y14.58%
EPS 5YN/A
EPS Q2Q%7.25%
Revenue 1Y (TTM)16.54%
Revenue growth 3Y43.68%
Revenue growth 5Y2.84%
Sales Q2Q%12.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMO Yearly Revenue VS EstimatesEMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.10 indicates a rather cheap valuation of EMO.
The average S&P500 Price/Earnings ratio is at 27.25. EMO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 3.1
Fwd PE N/A
EMO Price Earnings VS Forward Price EarningsEMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 2.1
EV/EBITDA N/A
EMO Per share dataEMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

5

5. Dividend

5.1 Amount

EMO has a Yearly Dividend Yield of 8.74%, which is a nice return.
EMO's Dividend Yield is rather good when compared to the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 8.74%

5.2 History

The dividend of EMO decreases each year by -14.49%.
EMO has been paying a dividend for at least 10 years, so it has a reliable track record.
EMO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-14.49%
Div Incr Years3
Div Non Decr Years3
EMO Yearly Dividends per shareEMO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5.3 Sustainability

11.19% of the earnings are spent on dividend by EMO. This is a low number and sustainable payout ratio.
DP11.19%
EPS Next 2YN/A
EPS Next 3YN/A
EMO Yearly Income VS Free CF VS DividendEMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
EMO Dividend Payout.EMO Dividend Payout, showing the Payout Ratio.EMO Dividend Payout.PayoutRetained Earnings

More info and screens

CLEARBRIDGE ENERGY MIDSTREAM

NYSE:EMO (7/31/2025, 8:20:31 PM)

47.87

+0.48 (+1.01%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)07-28 2025-07-28
Earnings (Next)01-26 2026-01-26
Inst Owners30.03%
Inst Owner Change-0.04%
Ins Owners0%
Ins Owner Change0.95%
Market Cap870.76M
Analysts0
Price TargetN/A
Short Float %0.48%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 8.74%
Yearly Dividend2.36
Dividend Growth(5Y)-14.49%
DP11.19%
Div Incr Years3
Div Non Decr Years3
Ex-Date08-22 2025-08-22 (0.36)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.1
Fwd PE N/A
P/S 62.55
P/FCF 2.1
P/OCF 2.1
P/B 1.76
P/tB 1.76
EV/EBITDA N/A
EPS(TTM)15.42
EY32.21%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)22.76
FCFY47.55%
OCF(TTM)22.76
OCFY47.55%
SpS0.77
BVpS27.27
TBVpS27.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 41.32%
ROE 59.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2119.25%
GM N/A
FCFM 2974.14%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.55%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.52
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 140.34%
Current Ratio 4.03
Quick Ratio 4.03
Altman-Z 1.92
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)213.41%
EPS 3Y14.58%
EPS 5YN/A
EPS Q2Q%7.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.54%
Revenue growth 3Y43.68%
Revenue growth 5Y2.84%
Sales Q2Q%12.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1867.47%
FCF growth 3YN/A
FCF growth 5Y26.17%
OCF growth 1Y1867.47%
OCF growth 3YN/A
OCF growth 5Y26.17%